Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
2.32M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
14.3K
-
Shares change
-
-1.54M
-
Total reported value, excl. options
-
$165K
-
Value change
-
-$16.8M
-
Number of sells
-
-12
-
Price
-
$11.47
Significant Holders of Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share (BLAC) as of Q4 2024
13 filings reported holding BLAC - Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share as of Q4 2024.
Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share (BLAC) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.3K shares
of 2.32M outstanding shares and own 0.61% of the company stock.
Largest 10 shareholders include CLEAR STREET LLC (14.2K shares), Tower Research Capital LLC (TRC) (105 shares), UBS Group AG (5 shares), Walleye Trading LLC (0 shares), RIVERNORTH CAPITAL MANAGEMENT, LLC (0 shares), WOLVERINE ASSET MANAGEMENT LLC (0 shares), Quarry LP (0 shares), COWEN AND COMPANY, LLC (0 shares), BERKLEY W R CORP (0 shares), and AQR Arbitrage LLC (0 shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.